OptimizeRx Stock Forecast
NASDAQ: OPRXConsumer DiscretionaryBusiness ServicesUSD
Market open · Delayed 15 min · as of Oct 9, 2:13 PM ET
OPRX analyst consensus
Consensus (6 analysts)
strong_buy
Avg. price target
$12.60+49.82%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering OptimizeRx (2026-10-09), 6 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $12.60, with a high estimate of $18.00 and a low estimate of $11.00. The average target implies upside of 49.8% from the current price of $8.41.
The spread between the highest and lowest targets is 63.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for OPRX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 17% |
| Buy | 5 | 83% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $11.00 | +30.80% |
| Average target | $12.60 | +49.82% |
| High target | $18.00 | +114.03% |